Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
GEVA > SEC Filings for GEVA > Form 8-K on 25-Sep-2013All Recent SEC Filings

Show all filings for SYNAGEVA BIOPHARMA CORP

Form 8-K for SYNAGEVA BIOPHARMA CORP


25-Sep-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On September 24, 2013, Synageva BioPharma Corp. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Goldman, Sachs & Co. as representative of the several underwriters listed on Schedule I thereto (the "Underwriters"), related to a public offering (the "Offering") of 2,750,000 shares of the Company's Common Stock at a price to the public of $56.63 per share pursuant to a registration statement on Form S-3 (File No. 333-185856) and a related prospectus supplement. In addition, the Company granted the Underwriters an option exercisable for 30 days from the date of the Underwriting Agreement to purchase, at the public offering price less any underwriting discounts and commissions, up to an additional 412,500 shares of Common Stock. Subject to customary closing conditions, the Offering is expected to close on September 30, 2013.

The above description of the Underwriting Agreement is qualified in its entirety by reference to the Underwriting Agreement, which is filed as Exhibit 1.1 hereto and incorporated herein by reference.

An opinion dated September 24, 2013 regarding the legality of the issuance and sale of the Common Stock in the Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K.

On September 23, 2013, the Company issued a press release announcing the Offering. Also on September 24, 2013, the Company issued a press release announcing the pricing of the Offering. Copies of the press releases are attached hereto as Exhibits 99.1 and 99.2, respectively, and are each incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

1.1 Underwriting Agreement, dated September 24, 2013, by and among the Company

        and Goldman, Sachs & Co., as representative of the several underwriters
        listed on Schedule I thereto.

 5.1    Opinion of Ropes & Gray LLP.

23.1    Consent of Ropes & Gray LLP (included in Exhibit 5.1 above).

99.1    Press Release dated September 23, 2013.

99.2    Press Release dated September 24, 2013.


  Add GEVA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for GEVA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.